(CIDRAP News) The number of pediatric influenza deaths outstripped last week's spike, and three more states reported widespread activity, the US Centers for Disease Control and Prevention (CDC) said today in its weekly surveillance update.
(CIDRAP News) For the second time this week, scientists have reported the discovery of a human antibody that, at least in theory, could lead to development of a vaccine or drug effective against most types of influenza A, including the deadly H5N1 avian flu virus.
Editor's note: This story was updated Feb 27 to include more information about an intradermal vaccine that Sanofi Pasteur is developing for the US market.
(CIDRAP News) The European Union has approved the first influenza vaccine injected with a shallow needle prick into the skin instead of a jab all the way into muscle, according to Sanofi Pasteur, the vaccine's manufacturer.
(CIDRAP News) – More evidence that the Salmonella strain responsible for a nationwide outbreak was present in two widely separated Peanut Corporation of America (PCA) facilities surfaced yesterday when Texas officials announced they had found the contaminant in a product from PCA's Plainview, Tex., processing plant.
(CIDRAP News) Americans who receive anthrax shotsmainly members of the militaryare likely to get five injections into muscle tissue instead of six subcutaneous injections, as a result of action today by the federal Advisory Committee on Immunization Practices (ACIP).
WHO confirms Vietnam's recent H5N1 deathThe World Health Organization (WHO) confirmed the death of a 23-year-old woman from H5N1 avian influenza. Her Feb 21 death raises the country's death toll to 53 among 109 cases, second only to Indonesia, which has 141 WHO-confirmed cases.[Feb 24 WHO statement]
(CIDRAP News) – The world's capacity to produce vaccines for an influenza pandemic has risen sharply in the past 2 years, but it would still take an estimated 4 years to meet the global demand if a pandemic emerged now, according to a report from an international strategy consulting firm.